Combining Sensitive Crossmatch Assays With Donor/Recipient Human Leukocyte Antigen Eplet Matching Predicts Living-Donor Kidney Transplant Outcome.

about

Combining Sensitive Crossmatch Assays With Donor/Recipient Human Leukocyte Antigen Eplet Matching Predicts Living-Donor Kidney Transplant Outcome.

Item

http://www.wikidata.org/entity/Q55509898

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Combining Sensitive Crossmatch ...... nor Kidney Transplant Outcome.

@en

Combining Sensitive Crossmatch ...... nor Kidney Transplant Outcome.

@nl

type

Item

label

Combining Sensitive Crossmatch ...... nor Kidney Transplant Outcome.

@en

Combining Sensitive Crossmatch ...... nor Kidney Transplant Outcome.

@nl

prefLabel

Combining Sensitive Crossmatch ...... nor Kidney Transplant Outcome.

@en

Combining Sensitive Crossmatch ...... nor Kidney Transplant Outcome.

@nl

P1476

Combining Sensitive Crossmatch ...... onor Kidney Transplant Outcome

@en

P2093

Anna Manonelles

http://www.w3.org/2001/XMLSchema#string

David Cucchiari

http://www.w3.org/2001/XMLSchema#string

Edoardo Melilli

http://www.w3.org/2001/XMLSchema#string

Elisabet Rigol-Monzó

http://www.w3.org/2001/XMLSchema#string

Ignacio Revuelta

http://www.w3.org/2001/XMLSchema#string

Jaume Martorell

http://www.w3.org/2001/XMLSchema#string

Josep M Cruzado

http://www.w3.org/2001/XMLSchema#string

Josep M Grinyó

http://www.w3.org/2001/XMLSchema#string

Nuria Montero

http://www.w3.org/2001/XMLSchema#string

Oriol Bestard

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.

Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss.

Interpreting Anti-HLA Antibody Testing Data: A Practical Guide for Physicians

OPTN/SRTR 2015 Annual Data Report: Kidney

Donor-specific antibodies adversely affect kidney allograft outcomes.

Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients

Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation.

Relationship between Mean Fluorescence Intensity and C1q/C3d-fixing capacities of anti-HLA antibodies.

The Risk of Transplant Failure With HLA Mismatch in First Adult Kidney Allografts From Deceased Donors.

Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss.

P304

926-938

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EKIR.2018.03.015

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fritz Diekmann

Maria Meneghini

P577

2018-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29989033

http://www.w3.org/2001/XMLSchema#string

P932

6035161

http://www.w3.org/2001/XMLSchema#string